

Prof Angela Tincani
Professor Angela Tincani is a senior consultant (previously director) at the Rheumatology and Clinical Immunology Unit of Aziende Socio Sanitaria Territoriali (ASST)-Spedali Civili and University of Brescia, Italy.
Professor Tincani has been involved in several international committees for education and research in the field of systemic autoimmune diseases. Professor Tincani’s primary clinical and research interests include the use of anti-rheumatic drugs in pregnant and lactating patients and the management of pregnancy in rheumatic disease patients, in addition to evaluating autoantibodies and autoimmune diseases as risk factors for poor gestational outcomes. She served as an expert for several European Alliance of Associations for Rheumatology (EULAR) recommendations, including “Points to consider for use of anti-rheumatic drugs before pregnancy and during pregnancy and lactation”. Together with Professor Andreoli, Professor Tincani is co-principal investigator of the “Italian Registry of Pregnancy in Rheumatic Diseases”.
Prof. Thrasyvoulos Tzellos gives an overview of HS treatment options. Dr Barry McGrath and Prof. Gregor Jemec provide their views on the HCP-patient relationship
Prof. Christos Zouboulis and Dr Axel Villani kick-off the webinar series by explaining the fundamentals of the HS disease story and pathophysiology
From practical tips to strategies that help support your patients' emotional well-being, find out how you can help your patients make positive changes
As HS is unique to every patient, their conversation should be too. Prompt your patients to download/print out this guide to take to future appointments
Many people with HS encounter a variety of medical experts from different specialties. Introduce your patients to the people they may meet along the way
Help your patients separate fact from fiction with this myth-busting guide to what HS really is and isn't